Skip to main content

Biopharma Startups

Updated November 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
915
Total Funding
$621.6M
Avg Funding
$24.9M
Global Reach
6
countries

Top Cities for Biopharma

London
Englewood
Melbourne
Philadelphia
Oxford
Cambridge

Recently Funded Companies

Export
London, United Kingdom

Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.

$28.9M raised
Oct 2024

Founder Contacts

41,000+ verified contacts

Englewood, United States

Origin Endoscopy offers medical products to control the hemostatic effects of gastrointestinal bleeding during endoscopy procedures.

$2.3M raised
Oct 2024

Founder Contacts

41,000+ verified contacts

Melbourne, Australia

AI driven personal health data platform

$1.1M raised
Oct 2024

Founder Contacts

41,000+ verified contacts

Philadelphia, United States

EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.

$275K raised
Oct 2024

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom

Caristo Diagnostics is a biotech company that provides diagnostic platforms for heart diseases, stroke, and diabetes.

$150K raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Concerto Biosciences measures, maps, and utilizes microbes to create therapies and products for agriculture and human health industries.

Sep 2024

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Mirai Bio provides access to end-to-end development capabilities with innovation at every step.

$50.0M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Ann Arbor, United States

Peptinovo develops novel nanoparticles targeting anti-cancer drugs to tumors for improved therapeutic outcomes and reduced side effects.

$1.3M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

London, United Kingdom

LIfT Biosciences® a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy

$13.4M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

San Diego, United States

Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.

$27.0M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Wellington, New Zealand

Lucidome Bio develops a simple vaccine to reduce ruminant methane emissions while solving an acute climate change issue.

$13.5M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Philadelphia, United States

Metabolics Pharma is a biotechnology company that offers pharmaceutical companies.

$5.5M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Los Angeles, United States

PictorLabs offers virtual staining technology using proprietary models powered by artificial intelligence.

$30.0M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

California, United States

Vironexis has the potential to transform immunotherapy and the way cancer is treated in the future.

$26.0M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

PhoreMost is a new-model drug discovery company based in Cambridge, UK.

$12.0M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.

$16.3M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Berkeley, United States

KuriBio builds a nanotechnology platform for therapeutic applications in oncology and beyond.

$150K raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.

$67.0M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Toronto, Canada

HDAC6, small molecule, peripheral neuropathy, cardiometabolic, pharmaceuticals, biotech, biopharma, life science

$3.2M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Cambridge, United States

EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.

$191.0M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Ann Arbor, United States

Evoq Therapeutics is a cancer immunotherapy company that provides disease-specific immune modulators.

$2.0M raised
Aug 2024

Founder Contacts

41,000+ verified contacts

Marseille, France

ImCheck Therapeutics designs and develops immunotherapeutic antibodies for the treatment of cancer and autoimmune disease.

$22.4M raised
Aug 2024

Founder Contacts

41,000+ verified contacts

Cincinnati, United States

Optimvia is a biopharmaceutical company that specializes in engineering proteins with tailored functions to combat disease.

$523K raised
Aug 2024

Founder Contacts

41,000+ verified contacts

Fort Collins, United States

Photonpharma develops an autologous cell therapy platform for the treatment of solid tumor cancers.

$2.5M raised
Aug 2024

Founder Contacts

41,000+ verified contacts

Raleigh, United States

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

$105.0M raised
Aug 2024

Founder Contacts

41,000+ verified contacts

Showing 501 to 525 of 915 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.

Average Funding
$24.9M
Total Funding Tracked
$621.6M
Countries Represented
6

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Cambridge
4 companies$253.0M
2.London
3 companies$58.7M
3.Philadelphia
2 companies$5.8M
4.Ann Arbor
2 companies$3.3M
5.Englewood
1 companies$2.3M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked